Free tool
FAERS Monitor: Varibar Pudding
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208844 or its brand name (Varibar Pudding, Barium Sulfate). Reports on generic versions are filed under their own applications.
Reports
262
Serious
195
74% of reports
Hospitalization
115
Death reported
31
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- renal failure18
- acute kidney injury17
- urticaria16
- chronic kidney disease15
- diarrhoea15
- rash14
- dyspnoea13
- vomiting13
- drug hypersensitivity12
- pruritus12
- abdominal pain10
- fatigue10
- nausea10
- no adverse event10
- pain10
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 8 |
| 2009 | 4 |
| 2010 | 8 |
| 2011 | 12 |
| 2012 | 12 |
| 2013 | 17 |
| 2014 | 12 |
| 2015 | 9 |
| 2016 | 18 |
| 2017 | 23 |
| 2018 | 18 |
| 2019 | 16 |
| 2020 | 12 |
| 2021 | 18 |
| 2022 | 20 |
| 2023 | 18 |
| 2024 | 10 |
| 2025 | 13 |
| 2026 | 6 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,897 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| chronic kidney diseaseSignal | 15 | 15.9 | 9.7 | 195 |
| renal failureSignal | 18 | 10.9 | 7.0 | 153 |
| acute kidney injurySignal | 17 | 8.9 | 5.6 | 113 |
| urticariaSignal | 16 | 7.7 | 4.8 | 87 |
| drug hypersensitivitySignal | 12 | 5.0 | 2.9 | 35 |
| no adverse eventSignal | 10 | 4.4 | 2.4 | 23 |
| abdominal painSignal | 10 | 3.5 | 1.9 | 15 |
| rashSignal | 14 | 2.6 | 1.5 | 12 |
| pruritusSignal | 12 | 2.5 | 1.4 | 10 |
| vomitingSignal | 13 | 2.2 | 1.3 | 8 |
| diarrhoea | 15 | 1.9 | 1.1 | 5 |
| dyspnoea | 13 | 1.8 | 1.1 | 4 |
| pain | 10 | 1.3 | 0.7 | 0 |
| fatigue | 10 | 1.0 | 0.6 | 0 |
| nausea | 10 | 1.0 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.